Registry of Toxic Effects of Chemical Substances (RTECS)
Hydrocyanic acid
RTECS #
MW6825000CAS #
74-90-8Updated
September 201Molecular Weight
27.03Molecular Formula
CHNSynonyms
Acide cyanhydrique (French)Acido cianidrico (Italian)
Aero Liquid HCN
Blausaeure (German)
Blauwzuur (Dutch)
Carbon hydride nitride (chn)
Cyaanwaterstof (Dutch)
Cyanwasserstoff (German)
Cyclon
Cyclone B
Cyjanowodor (Polish)
Evercyn
Formic anammonide
Formonitrile
Hydrogen cyanide
Hydrogen cyanide (ACGIH:OSHA)
Prussic acid
Prussic acid, unstabilized
RCRA waste number P063
Zaclondiscoids
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/cat | Lowest published lethal concentration: 550 mg/m3 | VCVN1* -,334,1988 | |
inhalation/human | lowest published toxic concentration: 20 mg/m3 | Gastrointestinal: Nausea or vomiting Cardiac: Pulse rate decreased with fall in BP | VCVN1* -,334,1988 |
inhalation/human | Lowest published lethal concentration: 100 mg/m3/1H | Brain and Coverings: Changes in circulation Liver: Other changes Kidney, Ureter, and Bladder: Other changes | VCVN1* -,334,1988 |
inhalation/human | Lowest published lethal concentration: 120 mg/m3/30M | Brain and Coverings: Changes in circulation Liver: Other changes Kidney, Ureter, and Bladder: Other changes | VCVN1* -,334,1988 |
inhalation/human | Lowest published lethal concentration: 200 mg/m3/10M | Brain and Coverings: Changes in circulation Liver: Other changes Kidney, Ureter, and Bladder: Other changes | VCVN1* -,334,1988 |
inhalation/human | lowest published toxic concentration: 5 mg/m3 | Behavioral: Headache | TOVEFN (2),39,2001 |
inhalation/human | lowest published toxic concentration: 20 mg/m3 | Cardiac: Pulse rate increased without fall in BP Gastrointestinal: Nausea or vomiting | TOVEFN (2),39,2001 |
inhalation/human | Lowest published lethal concentration: 100 mg/m3/1H | TOVEFN (2),39,2001 | |
inhalation/human | Lowest published lethal concentration: 120 mg/m3/30M | TOVEFN (2),39,2001 | |
inhalation/human | Lowest published lethal concentration: 200 mg/m3/10M | TOVEFN (2),39,2001 | |
inhalation/human | Lowest published lethal concentration: 200 mg/m3/10M | Behavioral: General anesthetic Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Nausea or vomiting | WHOTAC -,30,1970 |
inhalation/mammal (species unspecified) | Lowest published lethal concentration: 200 ppm/5M | AEPPAE 138,65,1928 | |
inhalation/mammal (species unspecified) | Lowest published lethal concentration: 36 ppm/2H | TABIA2 3,231,1933 | |
inhalation/man | Lowest published lethal concentration: 400 mg/m3/2M | 85GMAT -,75,1982 | |
inhalation/man | lowest published toxic concentration: 500 mg/m3/3M-continuous | Eye: Mydriasis (pupilliary dilation) Behavioral: Coma Lung, Thorax, or Respiration: Respiratory depression | HUTODJ 3,57,1984 |
inhalation/monkey | lowest published toxic concentration: 17 ppm/10M | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Respiratory stimulation | TOXID9 72,159,2003 |
inhalation/monkey | lowest published toxic concentration: 10 ppm/30M | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Respiratory stimulation | TOXID9 72,159,2003 |
inhalation/monkey | lowest published toxic concentration: 7.1 ppm/1H | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Respiratory stimulation | TOXID9 72,159,2003 |
inhalation/monkey | lowest published toxic concentration: 3.5 ppm/4H | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Respiratory stimulation | TOXID9 72,159,2003 |
inhalation/monkey | lowest published toxic concentration: 2.5 ppm/8H | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Respiratory stimulation | TOXID9 72,159,2003 |
inhalation/mouse | lethal concentration (50 percent kill): 177 ppm/29M | ENTOX* -,698,2005 | |
inhalation/mouse | lethal concentration (50 percent kill): 48.65 mg/m3/2H | TPKVAL 9,7,1967 | |
inhalation/mouse | lethal concentration (50 percent kill): 45.3 ppm/2H | TPKVAL 9,7,1967 | |
inhalation/mouse | lethal concentration (50 percent kill): 323 ppm/5M | TXAPA9 42,417,1977 | |
inhalation/rabbit | lethal concentration (50 percent kill): 208 mg/m3/35M | Brain and Coverings: Other degenerative changes Cardiac: Other changes Blood: Other changes | TSUJDP 13,263,1994 |
inhalation/rat | lethal concentration (50 percent kill): 150 ppm/30M | ENTOX* -,639,2005 | |
inhalation/rat | Lowest published lethal concentration: 138 ppm/15M | TOXID9 72,159,2003 | |
inhalation/rat | Lowest published lethal concentration: 127 ppm/30M | TOXID9 72,159,2003 | |
inhalation/rat | Lowest published lethal concentration: 88 ppm/1H | TOXID9 72,159,2003 | |
inhalation/rat | lowest published toxic concentration: 10 ppm | Ear: Change in acuity Ear: Change in cochlear structure or function | TOSCF2 66,131,2002 |
intramuscular/mouse | lethal dose (50 percent kill): 2700 µg/kg | BJPCAL 23,455,1964 | |
intramuscular/pigeon | lowest published lethal dose: 1500 µg/kg | FDWU** -,-,1931 | |
intramuscular/rabbit | lethal dose (50 percent kill): 486 µg/kg | JACTDZ 1(3),120,1982 | |
intraperitoneal/mouse | lethal dose (50 percent kill): 2990 µg/kg | BJPCAL 23,455,1964 | |
intraperitoneal/rabbit | lethal dose (50 percent kill): 1570 µg/kg | BJPCAL 23,455,1964 | |
intravenous/cat | lethal dose (50 percent kill): 810 µg/kg | NTIS** AD-A028-501 | |
intravenous/Dog | lethal dose (50 percent kill): 1340 µg/kg | NTIS** AD-A028-501 | |
intravenous/domestic animal | lethal dose (50 percent kill): 660 µg/kg | NTIS** PB158-508 | |
intravenous/guinea pig | lethal dose (50 percent kill): 1430 µg/kg | NTIS** AD-A028-501 | |
intravenous/man | lowest published toxic dose: 55 µg/kg | Lung, Thorax, or Respiration: Respiratory stimulation | NTIS** PB158-508 |
intravenous/monkey | lethal dose (50 percent kill): 1300 µg/kg | NTIS** AD-A028-501 | |
intravenous/mouse | lethal dose (50 percent kill): 990 µg/kg | NTIS** AD-A028-501 | |
intravenous/rabbit | lethal dose (50 percent kill): 660 µg/kg | NTIS** AD-A028-501 | |
intravenous/rat | lethal dose (50 percent kill): 810 µg/kg | NTIS** AD-A028-501 | |
ocular/rabbit | lethal dose (50 percent kill): 1040 µg/kg | Eye: Other eye effects Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory stimulation | JTOTDO 2,119,1983 |
oral/Dog | lowest published lethal dose: 4 mg/kg | HBAMAK 4,1340,1935 | |
oral/domestic bird | lowest published lethal dose: 600 µg/kg | FDWU** -,-,1931 | |
oral/duck | lowest published lethal dose: 3280 µg/kg | FDWU** -,-,1931 | |
oral/human | lowest published lethal dose: 570 µg/kg | PCOC** -,596,1966 | |
oral/mouse | lethal dose (50 percent kill): 3700 µg/kg | APFRAD 19,740,1961 | |
oral/pig | lowest published lethal dose: 2 mg/kg | AEHLAU 22,496,1971 | |
oral/pigeon | lowest published lethal dose: 14 mg/kg | FDWU** -,-,1931 | |
oral/rabbit | lowest published lethal dose: 4 mg/kg | HBAMAK 4,1340,1935 | |
oral/wild bird | lowest published lethal dose: 7500 µg/kg | FDWU** -,-,1931 | |
subcutaneous/cat | lowest published lethal dose: 1100 µg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/Dog | lowest published lethal dose: 1700 µg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/domestic bird | lowest published lethal dose: 100 µg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/frog | lowest published lethal dose: 60 mg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/guinea pig | lowest published lethal dose: 100 µg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/human | lowest published lethal dose: 1 mg/kg | SCJUAD 3(4),33,1967 | |
subcutaneous/mouse | lowest published lethal dose: 3 mg/kg | HBAMAK 4,1340,1935 | |
subcutaneous/pigeon | lowest published lethal dose: 2150 µg/kg | FDWU** -,-,1931 | |
subcutaneous/rabbit | lethal dose (50 percent kill): 2500 µg/kg | BJPCAL 23,455,1964 | |
subcutaneous/wild bird | lowest published lethal dose: 100 µg/kg | FDWU** -,-,1931 | |
unreported route/man | lowest published lethal dose: 1471 µg/kg | 85DCAI 2,73,1970 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/domestic animal | lowest published toxic dose: 75 mg/kg/30D- continuous | Brain and Coverings: Other degenerative changes Endocrine: Other changes Nutritional and Gross Metabolic: Changes in: Cl | JAPTO* 28,356,2008 |
oral/domestic animal | lowest published toxic dose: 10 mg/kg/4D- continuous | Behavioral: Alteration of classical conditioning | JAPTO* 28,356,2008 |
oral/domestic animal | lowest published toxic dose: 15 mg/kg/6D- continuous | Behavioral: Convulsions or effect on seizure threshold | JAPTO* 28,356,2008 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-ceiling concentration 4.7 ppm (skin) | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | EVHPAZ 11,163,1975 | |
TOXICOLOGY REVIEW | FNSCA6 2,67,1973 | |
TOXICOLOGY REVIEW | JOCMA7 1,281,1959 | |
TOXICOLOGY REVIEW | TOLED5 134,3,2002 | |
TOXICOLOGY REVIEW | CPEMM* 3,239,2002 | |
TOXICOLOGY REVIEW | TXCYAC 214,221,2005 | |
TOXICOLOGY REVIEW | ENTOX* -,639,2005 | |
TOXICOLOGY REVIEW | ENTOX* -,698,2005 | |
TOXICOLOGY REVIEW | REPTED 23,428,2007 | |
TOXICOLOGY REVIEW | HUTOX* -,661,1996 | |
TOXICOLOGY REVIEW | MUREAV 636,144,2007 | |
TOXICOLOGY REVIEW | CCACL* 21,691,2005 | |
TOXICOLOGY REVIEW | NEUCL* 15,711,1997 | |
TOXICOLOGY REVIEW | PRESR* 7,123,2006 | |
TOXICOLOGY REVIEW | NTAPM* -,629,1995 | |
TOXICOLOGY REVIEW | MUREAV 717,46,2011 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 10 ppm (10 mg/m3), JAN1993 | |
Occupational Exposure Limit-AUSTRALIA | ceiling concentration 10 ppm (11 mg/m3), JUL2008 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 5 mg(CN)/m3, JUL2008 | |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 10 ppm (11 mg/m3);KZW 40 ppm (44 mg/m3), skin, 2007 | |
Occupational Exposure Limit-BELGIUM | short term exposure limit 4.7 ppm (5 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 5 ppm (5 mg/m3), skin, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 1 mg/m3, short term exposure limit 5 mg/m3, skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 2 ppm (2 mg/m3), VLE 10 ppm (10 mg/m3), FEB2006 | |
Occupational Exposure Limit-GERMANY | MAK 1.9 ppm (2.1 mg/m3), 2011 | |
Occupational Exposure Limit-GERMANY | MAK 2 mg(CN)/m3, inhal, 2011 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 11 mg/m3, short term exposure limit 44 mg/m3, Skin, SEP2000 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 5 mg(CN)/m3, short term exposure limit 20 mg(CN)/m3, Skin, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 5 ppm (5 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 5 ppm (5.5 mg/m3), skin, MAY2012 | |
Occupational Exposure Limit-KOREA | ceiling concentration 10 ppm (11 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | peak 9.4 ppm (10 mg/m3), 2004 | |
Occupational Exposure Limit-MEXICO | time-weighted average 5 mg(CN)/m3, 2004 | |
Occupational Exposure Limit-NEW ZEALAND | ceiling concentration 10 ppm (11 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 5 ppm (5 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | short term exposure limit 4.7 ppm (5 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.3 mg/m3, CEILING 10 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 0.3 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 1.9 ppm (2.1 mg/m3), KZG-week 3.8 ppm (4.2 mg/m3), skin, JAN2011 | |
Occupational Exposure Limit-THAILAND | time-weighted average 10 ppm (11 mg/m3), JAN1993 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-C 11 mg/m3, Skin, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 10 ppm (11 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 10 ppm (11 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | short term exposure limit 10 ppm (11 mg/m3), skin, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 10 ppm (11 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 10 ppm (11 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 10 ppm (11 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 10 ppm (11 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HYDROGEN CYANIDE-air | short term exposure limit 4.7 ppm (Sk) | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 38530; Number of Industries 13; Total Number of Facilities 91; Number of Occupations 57; Total Number of Employees Exposed 3994; Total Number of Female Employees Exposed 254 | |
National Occupational Hazard Survey 1974 | Hazard Code 38530; Number of Industries 14; Total Number of Facilities 461; Number of Occupations 17; Total Number of Employees Exposed 2137 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division